Acetylaminofluorene inhibits nitric oxide production in LPS-stimulated RAW 264.7 cells by blocking NF-κB/Rel activation

Toxicology Letters

Volumn 104, Issue 3, 1999, Pages 195-202

  Jeon, Young Jin ^a   Han, Seung Hyun ^a   Kang, Jong Soon ^a   Koh, Woo Suk ^a   Yang, Kyu Hwan ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

2 Acetylaminofluorene; Inducible nitric oxide synthase; Nuclear factor B Rel

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; N (2 FLUORENYL)ACETAMIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; IMMUNE DEFICIENCY; IMMUNOTOXICITY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL;

2-ACETYLAMINOFLUORENE; ANIMALS; CARCINOGENS; CELL LINE; GENE EXPRESSION; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; ONCOGENE PROTEINS V-REL; RETROVIRIDAE PROTEINS, ONCOGENIC;

EID: 0033052597     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(98)00372-5     Document Type: Article

References (23)

1. Angel P., Imagawa M., Chiu R., Stein B., Imbra R.J., Rahmsdorf H.J., Jonat C., Herrlich P., Karin M. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell. 49:1987;729-739.
2. Aune T., Devereux T.R., Tveito K. Metabolism of 2-acetylaminofluorene by Clara cells, type II cells and alveolar macrophages isolated from rabbit lung, and use of a new chamber incubation mutagenicity test system. Cell Biol. Toxicol. 1:1985;109-122.
3. Chesrown S.E., Monnier J., Visner G., Nick H.S. Regulation of inducible nitric oxide synthase mRNA levels by LPS, INF-γ, TGF-β, and IL-10 in murine macrophage cell lines and rat peritoneal macrophages. Biochem. Biophys. Res. Commun. 200:1994;126-134.
4. Dunnett C.W. A multiple comparison procedure for comparing several treatments with a control. J. Am. Stat. Assoc. 50:1955;1096-1121.
5. Gilliland G., Perrin K., Blanchard K., Bunn H. Analysis of cytokine mRNA and DNA: Detection and quantitation by competitive polymerase chain reaction. Proc. Natl. Acad. Sci. USA. 87:1990;2725-2729.
6. Godambe S.A., Chaplin D.D., Takova T., Bellone C.J. Upstream NFIL-6-like site located within a DNase I hypersensitivity region mediates LPS-induced transcription of the murine interleukin-1β gene. J. Immunol. 153:1994;143-152.
7. Gorman C.M., Moffat L.F., Howard B.H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1982;1044-1051.
8. 15N]nitrate in biological fluids. Anal. Biochem. 126:1982;131-138.
9. Heflich R.H., Djuric Z., Fullerton N.F., Casciano D.A., Beland F.A. Metabolism of 2-acetylaminofluorene in the Chinese hamster ovary cell mutation assay. Environ. Mol. Mutat. 11:1988;167-181.
10. Hibbs J.B., Taintor R.R., Vavrin Z. Macrophage cytotoxicity: Role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science. 235:1987;473-476.
11. 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor-κB/Rel activation. Mol. Pharmacol. 50:1996;334-341.
12. Karupiah G., Xie Q.-W., Buller R.M.L., Nathan C., Duarte C., Macmicking J.D. Inhibition of viral replication by interferon-γ-induced nitric oxide synthase. Science. 261:1993;1445-1448.
13. Kim B.S., Kim D.H., Holsapple M.P., Yang K.H. Immunosuppressive effects of 2-acetylaminofluorene and 2-aminofluorene on murine splenocytes. Drug Chem. Toxicol. 12:1989;297-311.
14. Koh W.S., Chun Y.J., Yang K.H. Suppressive effects of 2-acetylaminofluorene on concanavalin A-stimulated murine splenocyte proliferation in vitro: Inhibition of interleukin-2 receptor expression. Biochem. Mol. Biol. Int. 32:1994;501-506.
15. Lee M., Kim H.M., Yang K.H. Down-regulation of protein kinase C in murine splenocytes: a potential mechanism for 2-acetylaminofluorene-mediated immunosuppression. Cancer Lett. 101:1996;53-57.
16. Leung K., Nabel G.J. HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-κB-like factor. Nature. 333:1988;776-778.
17. Lowenstein C.J., Alley E.W., Raval P., Snowman A.M., Snyder S.H., Russell S.W., Murphy W.J. Macrophage nitric oxide synthase gene: Two upstream regions mediate induction by interferon γ and lipopolysaccharide. Proc. Natl. Acad. Sci. USA. 90:1993;9730-9734.
18. Lowenstein C.J., Hill S.L., Lafond-Walker A., Wu J., Allen G., Landavere M., Rose N.R., Herskowitz A. Nitric oxide inhibits viral replication in murine myocarditis. J. Clin. Invest. 97:1996;1837-1843.
19. Palmer R.M.J., Ashton D.S., Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 333:1988;664-666.
20. Pierce J.W., Lenardo M., Baltimore D. Oligonucleotide that binds nuclear factor NF-κB acts as a lymphoid-specific and inducible enhancer element. Proc. Natl. Acad. Sci. USA. 85:1988;1482-1486.
21. Xie H., Chiles T.C., Rothstein T.L. Induction of CREB activity via the surface Ig receptor of B cells. J. Immunol. 151:1993;880-889.
22. Xie Q.-W., Whisnant R., Nathan C. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon γ and bacterial lipopolysaccharide. J. Exp. Med. 177:1993;1779-1784.
23. Xie Q., Kashiwabara Y., Nathan C. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:1994;4705-4708.